When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Karyopharm Therapeutics: Pullback Is Overdone
Karyopharm Therapeutics Inc.
Don't let schooling interfere with your education."- Mark Twain
Busted IPO Forum model portfolio holding Karyopharm Therapeutics (KPTI) reported Q4 results late this week. This report shows the company continues to make impressive progress with its initial rollout with recently approved XPOVIO. The results might have gotten a bit overlooked by the market as we saw a torrent of fourth-quarter reports this week. However, this progress should not go unnoticed so we will take a deeper look at Karyopharm's fourth quarter and what is ahead for this intriguing 'Tier 3'